Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

Similar articles for PubMed (Select 16110631)

1.

Central nervous system tumors.

Ashby LS, Pueschel JK, Shapiro WR.

Cancer Chemother Biol Response Modif. 2005;22:605-41. Review. No abstract available.

PMID:
16110631
2.

Gene expression profiling to analyze embryonal tumors of the central nervous system.

Packer RJ.

Curr Neurol Neurosci Rep. 2003 Mar;3(2):117-9. Review. No abstract available.

PMID:
12583839
3.

[Central nervous system cancers in childhood].

Valteau-Couanet D, Méar L.

Soins Pediatr Pueric. 2009 Dec;(251):21-2. French. No abstract available.

PMID:
19994710
4.
5.

Endocrine late effects of cancer treatment.

Cohen LE.

Endocrinol Metab Clin North Am. 2005 Sep;34(3):769-89, xi. Review.

PMID:
16085170
6.

Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line schedule.

Santisteban M, Nieto Y, De la Cruz S, Aristu J, Zubieta JL, Fernández Hidalgo O.

Clin Transl Oncol. 2007 Jul;9(7):465-7.

PMID:
17652061
7.

Brain tumors.

Obbens EA, Shapiro WR.

Cancer Chemother Biol Response Modif. 1993;14:606-27. Review. No abstract available.

PMID:
8312122
8.

Clinical trials referral resource. Current clinical trials in CNS tumors.

Kaplan RS, Schoenfeldt M.

Oncology (Williston Park). 2004 Mar;18(3):322, 327, 330 passim. No abstract available.

PMID:
15065702
9.

Acute lymphoblastic leukemia: an historical perspective.

Seibel NL.

Hematology Am Soc Hematol Educ Program. 2008:365. doi: 10.1182/asheducation-2008.1.365. No abstract available.

10.

Lymphoma: MGBG new studies, compassionate use in earlier disease.

Mascolini M.

AIDS Treat News. 1995 Dec 22;(no 237):4.

PMID:
11363077
11.

Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group study.

Taylor SA, Rankin C, Townsend JJ, Craig JB, Vance RB, Solank DL, Brown TD, Jaeckle K; Southwest Oncology Group.

Invest New Drugs. 2002 Feb;20(1):113-5.

PMID:
12003186
12.

Central nervous system germ cell tumors.

Balmaceda C, Modak S, Finlay J.

Semin Oncol. 1998 Apr;25(2):243-50. Review. No abstract available.

PMID:
9562458
13.

Hematology: Trials and tribulations in primary CNS lymphoma.

Ansell SM, Rajkumar SV.

Nat Rev Clin Oncol. 2010 Mar;7(3):125-6. doi: 10.1038/nrclinonc.2010.9. No abstract available.

PMID:
20190791
14.

Chloroquine in glioblastoma--new horizons for an old drug.

Munshi A.

Cancer. 2009 Jun 1;115(11):2380-3. doi: 10.1002/cncr.24288. Review. No abstract available.

15.

Preliminary clinical study of mithramycin (nsc-24559) in primary tumors of the central nervous system.

Ransohoff J, Martin BF, Medrek TJ, Harris MN, Golomb FM, Wright JC.

Cancer Chemother Rep. 1965 Dec;49:51-7. No abstract available.

PMID:
4285360
17.

[Treatment of central nervous system germ cell tumors].

Sawamura Y, Aoyama E.

No To Shinkei. 2005 Dec;57(12):1052-7. Review. Japanese. No abstract available.

PMID:
16375190
18.

Intra-arterial chemotherapy of primary brain tumors.

Newton HB.

Curr Treat Options Oncol. 2005 Nov;6(6):519-30. Review.

PMID:
16242056
19.

Bibliography. Current world literature. Brain and nervous system.

[No authors listed]

Curr Opin Oncol. 2000 May;12(3):B79-92. No abstract available.

PMID:
10841202
20.

[Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].

Thomas X, Pavan L, Le QH.

Bull Cancer. 2008 Jul-Aug;95(7):707-15. doi: 10.1684/bdc.2008.0645. Review. French.

PMID:
18755650
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk